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Summary
Rhizosecretion of recombinant pharmaceuticals from in vitro hydroponic transgenic plant
cultures is a simple, low cost, reproducible and controllable production method. Here, we
demonstrate the application and adaptation of this manufacturing platform to a human
antivitronectin IgG1 monoclonal antibody (mAb) called M12. The rationale for specific growth
medium additives was established by phenotypic analysis of root structure and by LC-ESI-MS/MS
profiling of the total protein content profile of the hydroponic medium. Through a combination
of optimization approaches, mAb yields in hydroponic medium reached 46 lg/mL in 1 week, the
highest figure reported for a recombinant mAb in a plant secretion-based system to date. The
rhizosecretome was determined to contain 104 proteins, with the mAb heavy and light chains
the most abundant. This enabled evaluation of a simple, scalable extraction and purification
protocol and demonstration that only minimal processing was necessary prior to protein A
affinity chromatography. MALDI-TOF MS revealed that purified mAb contained predominantly
complex-type plant N-glycans, in three major glycoforms. The binding of M12 purified from
hydroponic medium to vitronectin was comparable to its Chinese hamster ovary (CHO)-derived
counterpart. This study demonstrates that in vitro hydroponic cultivation coupled with
recombinant protein rhizosecretion can be a practical, low-cost production platform for
monoclonal antibodies.
Introduction
Monoclonal antibodies (mAbs) are the most commercially impor-
tant products in the field of biologics (Aggarwal, 2009). Thera-
peutic mAbs often serve a large patient population, involving
long-term therapy with high doses, for example the chimeric
monoclonal antibody Rituximab, used for the treatment of
haematological cancers and autoimmune diseases such as rheu-
matoid arthritis (Edwards et al., 2004; Saini et al., 2011).
Consequently, extremely high amounts of mAbs are needed to
meet demand. The main challenge for mAb manufacturing is the
development of scalable, consistent and reproducible systems for
their production at moderate costs (Shukla and Th€ommes, 2010).
To date, mammalian cell culture has been the method of choice.
However, in spite of the high production capacity achieved after
over a decade of optimization, costs associated with bioreactor
establishment/maintenance, cell culture medium and purification
are still very high.
Transgenic plants offer a low cost, readily scalable alternative
to mammalian cell production systems. Since mAbs were first
produced in transgenic plants in 1989 (Hiatt et al., 1989), the
feasibility of the plant expression system has been demonstrated
in numerous reports (reviewed in De Muynck et al., 2010;
Yusibov et al., 2011). Initial scepticism regarding the practicalities
of establishing a regulatory compliant production process that
could match the mammalian cell culture production system has
eased, following regulatory approval for Phase I safety trials of
plant-derived mAbs in both the USA and UK (www.icongenet-
ics.com/html/5954.htm; www.pharma-planta.org). Importantly,
Protalix’s ElelysoTM (taliglucerase alfa) recently became the first
plant-derived pharmaceutical to be approved for human use by
the FDA, followed by several other countries’ regulatory agencies
(http://www.protalix.com/procellex-platform/overview-procellex-
platform.asp). This milestone established plant systems as man-
ufacturing platforms for pharmaceutical proteins, paving the way
for other plant-produced recombinant pharmaceuticals.
Rhizosecretion has been investigated as a process which could
be exploited to harvest recombinant protein when genetically
modified plants were grown hydroponically, as a way to simplify
downstream processing (Borisjuk et al., 1999). Other advantages
were also proposed: the possibility of recombinant product
extraction throughout the life of the plant, exposure to fewer
proteolytic enzymes, the fact that the final product is fully
secreted and therefore potentially more homogeneous than a
product extracted from plant tissue and the potential for
continuous in-line extraction process (Drake et al., 2009).
Drake et al. (2009) used plant-growth regulators to improve
rhizosecretion yields of two model mAbs and an HIV microbicide
candidate, cyanovirin-N (CV-N) (Drake et al., 2009). They dem-
onstrated that the auxin a-naphthaleneacetic acid (NAA), added
to hydroponic medium at 1 mg/L, increased antibody yields 50-
fold and the yield of CV-N sixfold over a 7-day period. The
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maximum rhizosecretion rates achieved were 0.95 lg/mL/week
for Guy’s 13 and 6.25 lg/mL/week for CV-N.
Here, we applied these findings to the rhizosecretion of a
recombinant human IgG antibody, M12. This mAb was derived
from a single-chain variable fragment (scFv) selected from a na€ıve
human phage display library using a breast carcinoma cell line
(Raven et al., 2011). M12 binds to vitronectin, a plasma glyco-
protein which may influence tumour haemostasis and malignancy
(Bloemendal et al., 2004; Kirchhoff et al., 2012). Transgenic
tobacco plants which expressed M12 at high levels in leaf tissue
were used, and studies were undertaken to determine whether
this was reflected in the yields produced by rhizosecretion. The
aim of this work was to optimize hydroponic cultivation and
rhizosecretion of the antibody, to understand the biological
limitations of the production system and to identify the down-
stream processing and purification challenges resulting from the
manipulation of the plant cultivation process. Following on from
our previous findings, we included NAA in our culture media and
compared mAb yields in plants cultured either in MS medium
(Murashige and Skoog, 1962) or MS supplemented with addi-
tional nitrate (MSN), a formulation that has previously boosted
mAb production in tobacco BY-2 cells (Holland et al., 2010). The
rhizosecretion system was further characterized with microscopy
analysis of roots, a proteomic profile of hydroponic medium, the
rhizosecretome, and glycan structure and functionality analysis of
the M12 mAb. Finally a simple, scalable standard operating
procedure was developed for purification of rhizosecreted mAbs
from hydroponic culture.
Results
M12 antibody is consistently rhizosecreted at high yields
in nitrate-enriched hydroponic medium
Tobacco plants expressing a secreted version of M12 antibody
were cultivated inside glass jars in either MS medium or MSN
medium, containing NAA and gelatin. Samples were collected
weekly during the harvesting phase (weeks 11–18) and quantified
by ELISA. M12 yields in MSN medium were significantly higher
than in MS medium at all time points (Student’s t-test,
P < 0.0001). As shown in Figure 1a, at week 11, the average
M12 level accumulated in hydroponic medium of plants grown in
MS medium was ~1 lg/mL and decreased to undetectable levels
after week 13. However, the mean yield for the MSN group was
35 lg/mL at week 11. At week 12, the mean yield increased to
46 lg/mL in the MSN plants (with a maximum of 75 lg/mL
measured in the highest yielding individual plant). The levels
decreased slightly thereafter, but were maintained between 13
and 25 lg/mL until week 18. Over the eight weeks of the
harvesting phase, an average of 23 lg/mL per week of M12
antibody was produced by the plants in the MSN group.
Rhizosecreted M12 from MS and MSN groups was also
visualized on a Western blot probed with antiheavy chain or
antilight chain antiserum (Figure 1b,c). With antiheavy chain
antiserum, under nonreducing conditions, there were three major
high molecular weight bands, representing the full-length anti-
body and two assembly intermediate or degradation products, in
the leaf-derived positive control and in M12 harvested from
plants cultured in MS or MSN. The intensity of all three bands was
much stronger for the MSN sample including the 150 kDa full-
length antibody (arrow). Under reducing conditions, a 50 kDa
strong band was observed in the MSN sample (arrow), which was
not observed in the MS sample. The same band was observed in
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Figure 1 M12 production in MS or MSN hydroponic medium. (a) M12
yields in hydroponic medium measured by ELISA of plants cultivated in MS
or MSN. Values are mean  SE of a minimum of seven plants. (b) Western
blot of pooled samples from week 11 detected with anti-gamma chain
antiserum, at reducing and nonreducing conditions. (c) Western blot of
pooled samples from week 11 detected with anti-lambda chain antiserum,
under reducing and nonreducing conditions. M = molecular weight
marker. +ve = tobacco leaf-derived purified M12 antibody control
(40 ng). Mr (kDa) is indicated on the left. Red arrow indicates fully
assembled antibody, blue arrow indicates heavy chain, and green arrow
indicates light chain.
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the purified tobacco leaf-derived M12 positive control. A further
10–15 kDa band was detected in both MS and MSN samples,
suggesting degradation of the heavy chain. When detected with
antilight chain antiserum under nonreducing conditions, the same
banding pattern was observed for both MS and MSN samples,
but the 150 kDa full-length antibody (arrow) was much more
intense in the MSN sample, confirming the result observed with
antiheavy chain antiserum. Under reducing conditions, a 25 kDa
band of comparable intensity was detected in both samples
suggesting that the effect induced by the high nitrate medium is
exclusive to the heavy chain. No bands were observed for the WT
samples under any conditions.
The root phenotype in the rhizosecretion is consistent
with auxin treatment
The rhizosecretion-based production system used here involved
treatment of plants with NAA over a prolonged period. This was
associated with an altered root phenotype that was evident to the
naked eye. Whilst wild type and M12 control root tips appeared
similar and normal, those treated with NAA displayed root hair
proliferation and elongation, and initiation of nonelongating
lateral root primordia along the entire length of the vascular
cylinder right to the root tip. This phenotype was more
pronounced in M12 3NAA roots compared to M12 1NAA roots.
Microscopy of roots from plants treated with NAA illustrates a
proliferation of elongated root hairs (Figure 2, top panel, M12
1NAA and M12 3NAA), compared to plants not treated with NAA
(Figure 2, top panel, WT and M12). Root hairs were remarkably
long in the group of plants receiving three doses of NAA, so much
so that they formed a mat that had to be pulled apart with
forceps to allow for imaging of individual root tips.
The nodular structures (Figure 2, bottom panel, M12 1NAA
and M12 3NAA) were identified under magnification as
nonelongating lateral root primordia. Their proliferation was
more remarkable in the group of plants receiving three doses
of NAA, whilst they could not be observed in the plants not
treated with NAA (Figure 2, bottom panel). These lateral root
primordia initiated but failed to elongate and thus did not
result in disruption to enclosing root cortical or epidermal cell
layers.
The rhizosecretome is a complex mix of proteins; the
recombinant antibody chains are the most abundant
proteins
In order to further characterize the rhizosecretion platform and to
address the challenge of developing downstream processing and
WT M12 M12 1NAA M12 3NAA
WT M12 M12 1NAA M12 3NAA
Figure 2 Root phenotypes after different NAA
treatments. Root tips from 8-week-old wild-type
and M12 tobacco plants grown in hydroponic
medium (M12) or hydroponic medium
supplemented with NAA. M12 1NAA plants
received one 1 mg/L dose of NAA, and M12
3NAA plants received three 1 mg/L doses of NAA
(1 per week) over a period of 3 weeks. Scale bars:
top row, 100 lm; bottom row 30 lm. NAA,
a-naphthaleneacetic acid.
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purification strategies, a proteomic analysis was performed to
identify the range and relative abundance of rhizosecreted
proteins in the optimized hydroponic medium of tobacco plants
expressing M12. The protein content of hydroponic medium
(week 11), which was shown by Western blot to contain M12
heavy and light chains (Figure 1b,c), was initially concentrated
and then resolved by SDS-PAGE (Figure 3a). A range of protein
bands between 10 and 150 kDa was observed, and these were
subsequently identified by LC/MS/MS.
A total of 104 proteins were identified (Table S1). The proteins
identified in each sample were ranked according to the expo-
nentially modified protein abundance index (emPAI). M12 heavy
and light chains were the two most abundant individual proteins,
accounting for 13% and 14% of the total protein content,
respectively (Figure 3b). The other groups of plant proteins
identified in hydroponic medium were chitinases, glucosidases,
pathogenesis-related proteins and peroxidases. Two proteases
were identified in the medium—a subtilisin-like protease and
CND41, a chloroplast nucleoid DNA-binding protein, which
contains an aspartic protease domain (Murakami et al., 2000)—
comprising only 3% of the total protein content.
M12 mAb is readily and efficiently purified from
hydroponic medium
A simple, scalable standard operating procedure for purification
of rhizosecreted mAbs from hydroponic culture was developed,
to identify the potential efficiency of purification.
At 1 L scale, coarse filtration followed by 0.45 lM microfiltra-
tion resulted in permeate 98% of total volume and 2% retentate
remaining at the end of the filtration. The overall recovery of the
mAb at this stage was 99%. During the course of the UF, mAb
concentration increased from 40 to 153 lg/mL which was in line
with the degree of dewatering achieved. Following Protein A
chromatography, overall recovery of the mAb was 84% account-
ing for all mAb found in all fractions, with 83% recovery of the
product present in the two principal product elution fractions.
At 100 mL scale, hydroponic medium was passed directly
through a 0.22 lm filter before purification by protein A affinity
chromatography. Samples were visualized on a Coomassie-stained
SDS-PAGE gel (Figure 4a). The extraction and concentration of the
antibody, calculated to be ~85-fold, was achieved at a very high
level of purity (Figure 4a, lane 5). Western blot of purified M12
under nonreducing conditions revealed the presence of the fully-
assembled antibody (Figure 4b, arrow) and two additional bands at
~125 and ~100 kDa (Figure 4b). This indicates that antibody
degradation or assembly intermediate products were co-purified
with the whole antibody. The final purified antibody yield from
100 mL medium was 480 lg. The recovery of mAb was 80%.
Rhizosecreted M12 mAb consists mainly of complex
glycoforms
The glycosylation pattern of purified rhizosecreted M12 mAb at
the first, fourth and seventh week of the harvesting period
(weeks 11, 14 and 17) was investigated. The relative results are
shown in Table 1. At the first week, M12 purified from
hydroponic medium contained mainly complex-type plant
N-glycans, with three major glycoforms: M3Gn2X1F1, M3Gn3X1F1
and M3Gn4X1F1. This was unchanged at the third week, but the
sample harvested at the seventh week did contain small
percentages of two additional glycoforms, including a high-
mannose type (M7Gn2). In comparison, M12 antibody
extracted and purified from root tissue at the seventh week
(Table 1, final column) contained a similar heterogeneity of
glycoforms to the hydroponic medium, but with a greater
proportion of M7Gn2.
Rhizosecreted M12 binds to vitronectin
In order to verify the M12 binding activity to vitronectin, an ELISA
was undertaken with antibody purified from hydroponic medium
in comparison with a purified Chinese hamster ovary (CHO)-
derived M12 control. Both antibody samples bound the cognate
antigen, and no differences were seen between the binding
curves (Figure 5).
250
150
100
75
50
37
25
10
20
15
% weight
(a)
(b)
Figure 3 The rhizosecretome. (a) SDS-PAGE separation of hydroponic
medium proteins and Coomassie brilliant blue staining for the
identification of proteins by LC-ESI-MS/MS. Samples were concentrated 20
times prior to loading. Lane 1—molecular marker (Mr is indicated on the
left in kDa) and lane 2—hydroponic medium sample (MSN + NAA). (*)
bands correspond to M12 heavy and light chain. (b) Categories of
rhizosecreted proteins identified by LC/MS. Categories are displayed in
percentages calculated according to the emPAI. The PAI was calculated by
dividing the number of observed peptides by the number of observable
peptides per protein, which was then exponentially modified to make it
directly proportional to protein content. NAA, a-naphthaleneacetic acid;
emPAI, exponentially modified protein abundance index.
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Discussion
Monoclonal antibodies are valuable therapeutic biomolecules
often required in large quantities for the treatment of a range of
conditions and diseases. To date, mAbs have been produced
commercially in mammalian cell culture, but the costs associated
with this manufacturing system are high. Plants are an inexpen-
sive alternative to mammalian systems, offering additional
advantages such as low risk of contamination with human
pathogens. Here, the production of the antivitronectin M12 mAb
was explored using a relatively low-tech, very low-cost plant-
based expression platform.
An initial assessment of M12 antibody transgenic plants
demonstrated a higher level of recombinant antibody rhizose-
creted in the hydroponic medium, compared to previous
published reports for mAbs. The concentration of the murine
Guy’s 13 mAb following rhizosecretion into MS medium was
originally reported as 0.05 lg/mL (Drake et al., 2009), compared
to 0.3 lg/mL for M12 here (data not shown). Guy’s 13 yields
were improved nearly 50-fold when the auxin NAA was included
into the hydroponic medium for 4 weeks prior to harvesting. In
the present study, a significant increase in M12 yield was also
obtained in MS medium when NAA was used, reaching 7.5 lg/
mL at week 8 (data not shown). However, the initial high yields
were not maintained and decreased during harvesting phase
(week 11 onwards) to ~1 lg/mL, probably due to plant ageing
and production of proteases.
Utilization of nitrate-enriched medium (MSN) greatly enhanced
M12 rhizosecretion levels well beyond those observed in MS
medium, and this enhancement was maintained throughout the
harvesting phase. A nitrate enrichment strategy was previously
reported in BY-2 cell culture, where the yield of a human IgG1,
2G12, was improved 10- to 20-fold in medium with increased
concentration of nitrate (Holland et al., 2010). A similar effect
was observed in hairy root cultures for the same M12 antibody,
reaching a maximum secreted concentration of 5.9 lg/mL
(Hakkinen et al., 2014). In the present study, a peak M12
concentration of over 45 lg/mL was observed. This figure is
higher than any previously reported either for a rhizosecreted
antibody or for antibody produced in extracellular medium of BY-
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Figure 4 M12 purification from hydroponic medium using protein A
chromatography. (a) Coomassie-stained SDS-PAGE under reducing
conditions with samples from M12 purification from hydroponic medium.
Lane 1—protein marker; lane 2—M12 positive control (1 lg); lane 3—
0.22 lm filtered hydroponic medium; lane 4—Protein A column flow
through, 5 to 10—elution fractions 1 to 6. (b) Western blot of elution
fraction 1 under nonreducing conditions; 1 lL of a 1 : 10 dilution was
loaded onto the gel. Arrow indicates fully assembled antibody. Mr is
indicated on the left in kDa.
Table 1 Glycosylation analysis of rhizosecreted M12 mAb at the first,
fourth and seventh week of the harvesting phase (weeks 11, 14 and
17 from culture initiation, respectively) and of M12 extracted from
root tissue after the final collection. Major glycoforms and their
masses are shown; their relative abundance is expressed as a
percentage of total glycoforms
Glycoform
Mass
(Da)
Medium
1st
Medium
4th
Medium
7th Root 7th
Rel. abundance (%)
High mannose
M3Gn4 2487.99 Not detected Not detected 3 Not
detected
M7Gn2 2730.04 Not detected Not detected 2.2 5.6
Complex
M3Gn3X1 2416.95 4.3 5.4 3 6.2
M3Gn4X1 2620.03 9 10.2 5.8 8.2
M3Gn2X1F1 2359.93 15.5 16.4 24.3 25.4
M3Gn3X1F1 2563.01 21.6 24 29.4 18.1
M3Gn4X1F1 2766.09 49.6 44 32.3 36.5
Figure 5 M12 binding activity to vitronectin measured by ELISA. Purified
M12 from hydroponic medium (■) was incubated alongside a Chinese
hamster ovary-derived purified M12 (●) and PBS (▼) on ELISA plates
coated with human vitronectin. Bound M12 was detected with HRP-
labelled anti-lambda light chain antiserum. The data represent an average
from three independent experiments with three replicates each with
standard deviations.
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2 tobacco cells or hairy root cultures (De Guzman et al., 2011;
Drake et al., 2009; Hakkinen et al., 2014; Xu et al., 2011).
Western blot analysis under nonreducing conditions confirmed
the increase of the fully assembled M12 mAb yields obtained
when nitrate-enriched medium was used. Under reducing con-
ditions, however, it was shown that the medium boosted yield of
mAb heavy chain but not light chain, suggesting that the nitrate
effect may not be purely due to an increase in protein synthesis.
In our future studies, we shall seek to elucidate the mechanism by
which this enhancement of mAb yield in medium with elevated
nitrate occurs.
We have previously demonstrated that root hairs can secrete
mAb (Drake et al., 2003). In an unpublished study, we also
previously observed that NAA increased root hair formation along
the length of the root in hydroponic cultures of tobacco
(Figure S1). In the present study, this was also observed and
characterization of the root tips in the rhizosecretion system by
microscopy was undertaken. Here, a clear increase in the amount
and length of root hairs on root tips, following application of
NAA, was demonstrated. Formation of root hairs is likely to have
provided increased surface area for the production and secretion
of recombinant antibodies. Another observation was the striking
development of lateral root primordia. An important event in the
formation of lateral roots is the reorganization of endodermal,
cortical and epidermal layers of cells to allow the emergence of
lateral root primordia. It has been suggested that these tissues
actively participate in the emergence process by expressing cell
wall remodelling enzymes to loosen the tissues (Laskowski et al.,
2006; Neuteboom et al., 1999; Roberts et al., 2002). Analysis of
root transcripts induced by auxin in the tissues surrounding lateral
root primordia has identified mRNAs encoding several cell wall
remodelling genes, including a subtilisin-like protease and
expansins (Swarup et al., 2008), and both were identified in
our study, in the rhizosecretome.
LC-ESI-MS/MS analysis was used for determination of the
rhizosecretome, to the best of our knowledge the first of its kind
for transgenic tobacco plants in hydroponic culture. After
identification, the abundance of each protein was calculated
using the emPAI (Ishihama et al., 2005), a well-established index
which has been used for proteomic studies in diverse organisms
(Degnan et al., 2009; Eubel et al., 2008; Morris et al., 2007;
Ohta et al., 2010; Rice et al., 2010; Taylor et al., 2011). A total of
104 proteins were identified, and the light and heavy antibody
chains were the most abundant proteins. The other main groups
of proteins identified—chitinases, endoglucanases, pathogenesis-
related proteins and peroxidases—have all been described as
stress-related or secreted proteins with defence activity (Bais
et al., 2004). They are consistent with proteins identified in an
extracellular proteomic analysis of medium in which BY-2 cells
(Basu et al., 2006; Okushima et al., 2000) Arabidopsis thaliana
and Brassica napus roots had been cultured (Basu et al., 2006).
Less abundant groups included proteases, protease inhibitors,
carbohydrate metabolism, oxidative stress and expansins. One of
the proteases identified was a subtilisin-like protease (GenBank
accession # GI:148299083—Table S1), first identified in the
extracellular medium of Nicotiana tabacum BY-2 culture (Navarre
et al., 2012). The presence of proteases in the medium is not
attractive for the production of antibodies by rhizosecretion;
however, we have previously demonstrated that hydroponic
culture medium contained significantly lower proteolytic activity
than tobacco leaf intercellular fluid (Drake et al., 2009). In
addition, the Guy’s 13 mAb produced by rhizosecretion in this
report was less degraded than the leaf-derived counterpart. In the
present study, the amount of proteases in the MSN medium
accounted for only 3% of all the proteins.
An important advantage of the rhizosecretion system, in
comparison with extraction from vegetative tissues, is the
potential for simplified purification. BY-2 cells and hairy roots
also have a similar advantage because they are also based on the
secretion of the recombinant protein into a simple medium, but
both systems require expensive bioreactors for cultivation. BY-2
cell culture also requires more complex purification steps, as the
cells retain large volumes of medium and produce high amounts
of extracellular polysaccharides resulting in the need for
additional pressing and filtration steps (Hellwig et al., 2004).
Protein A is the affinity ligand of choice for commercial mAb
purification, and the simplification of downstream processing is
likely to revolve around reduction of the preparative steps
normally required prior to protein A chromatography. An efficient
standard operating procedure was established for hydroponic
medium at 1 L scale, that involved coarse filtration, followed by
0.45 lm microfiltration and concentration by ultrafiltration, a
process that is broadly in line with standard practice. Here, we
also demonstrated that purification of M12 from hydroponic
medium by protein A chromatography was possible after a single
microfiltration step. Eighty per cent recovery of antibody was
achieved in this preliminary study. Thus, antibody purification
from hydroponic medium could be achieved using established
downstream processing protocols for recombinant mAbs, avoid-
ing all the preliminary processing steps that are required for other
plant cell-based or tissue-based expression systems. The quality
and functionality of the purified antibody purified from medium
was confirmed.
The structure of complex glycans in plants is known to differ
from those in mammals (Bosch and Schots, 2010; Faye et al.,
2005; Whaley et al., 2011), and it has been suggested that plant
glycosylated mAbs may have altered Fc effector functionality
(Forthal et al., 2010; Jin et al., 2008). The relevance of these
glyco-epitopes in the context of human therapy is still a matter for
study (Faye et al., 2005). However, phase I clinical trials in
humans with antibodies produced in plants given orally (Ma
et al., 1998), subcutaneously (McCormick et al., 2008) or vagi-
nally (www.pharma-planta.org) have shown no immunological
responses to plant-specific glycans following antibody adminis-
tration.
As the antibody chains traffic through the ER and Golgi, the
glycosylation process may not proceed to completion; therefore,
N-glycan structures can be heterogeneous (Bosch and Schots,
2010; Elbers et al., 2001). It has been reported that when
recombinant antibodies were purified from tobacco leaf tissue,
diverse glycoforms, including high-mannose species, were
detected, which was probably due to the extraction of a mixture
of fully secreted apoplastic molecules and of those that were still
in transit through the secretory pathway (Cabanes-Macheteau
et al., 1999). Extraction of recombinant proteins from hydroponic
medium should in theory result in a more homogeneous mixture
as all of the recombinant protein has been secreted. Indeed, we
have shown here that rhizosecreted antibody collected at the
beginning and middle of the harvesting phase (1st and 4th
weeks) consisted only of complex glycoforms. At a later stage
(7th week), a very small percentage of high-mannose glycans
were detected, but this was less than that found following
antibody purification from transgenic root tissue. Heterogeneity
of antibody glycoforms has been associated with senescence and
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degradation (Elbers et al., 2001; Stevens et al., 2000). The
appearance of high-mannose glycans may have been due to
cell death caused by a combination of auxin treatment and
plant senescence with subsequent release of intracellular
antibody.
Glyco-engineering in plants has advanced rapidly, as demon-
strated in several published reports (reviewed by Bosch et al.,
2013). For example, antibody molecules lacking the plant-specific
glycans can be produced in b-1,2-xylosyltransferase and a-1,3-
fucosyltransferase RNAi-mediated knocked-down plants (Strasser
et al., 2008). Neuraminic acid, a glycan not found in plant
proteins, has also been added to a plant-produced protein by co-
expression with protein sialylation pathway genes (Jez et al.,
2013). In future, the rhizosecretion platform could be used to
produce glycoengineered proteins using appropriately modified
transgenic plants.
In this study, we have identified a cultivation protocol for
transgenic tobacco that produces a high yield of glycosylated,
functional monoclonal antibody. Despite the anatomical changes
induced in the root system, and the consequent complex mixture
of host proteins released into the hydroponic medium, it was
demonstrated that antibody extraction and purification was
extremely simple, involving a very small number of steps.
Establishment of hydroponic plant cultures is simple and eco-
nomical, using disposable or recyclable vessels, allowing con-
trolled and contained production with inexpensive, defined
medium. The system is scalable and amenable to automation,
which would only require medium changes on a weekly basis.
From the volume of hydroponic medium obtained in these studies
and the yield achieved, an estimated 13 mg of functional,
purified M12 per batch of 10 plants can be produced over a 15-
week production period. Considering the amount of jars that can
be stacked per m3, 1 kg of purified antibody could be produced
in a space of 320 m3 in the same period.
In future studies, it will be interesting to compare rhizosecre-
tion of recombinant proteins in different cultivars of tobacco and
other plant species. It will also be important to make this an
‘animal-free’ production platform by finding an alternative to
gelatin, which has been used as a stabilizer for the production of
mAbs in the system to date. Removal of gelatin from the
cultivation process reduces M12 concentration in medium by
~50% (data not shown). Alternatives to gelatin may include plant
proteins, for example derived from soya or, conceivably, animal
proteins such as albumin that have been produced in transgenic
plants (He et al., 2011).
In conclusion, we propose that the rhizosecretion production
platform is a simple, low-tech and economical method to produce
high-quality mAbs with a variety of applications.
Experimental procedures
Establishment and maintenance of plant cultures
Transgenic tobacco (N. tabacum cv. Petite Havana SR1) plants
expressing the heavy and the light chains of the M12 antibody
were previously generated by Agrobacterium-mediated transfor-
mation with the expression vector pTRAkc-MTAD (Raven et al.,
2011). Briefly, the heavy and the light chain coding sequences,
including leader sequences for secretion to the apoplast, were
introduced as separate expression cassettes within a single
T-DNA, driven by the double-enhanced Cauliflower mosaic virus
(CaMV) 35S promoter. The expression cassettes were flanked by
scaffold attachment regions.
Seeds from wild-type tobacco plants (WT) or a M12 homozy-
gous line were surface-sterilized and germinated as previously
described (Drake et al., 2003). Seedlings were grown to a stem
length of circa 1 cm and transferred individually to glass jars
containing liquid Murashige and Skoog (MS) (Murashige and
Skoog, 1962) medium under sterile conditions so that the root
was immersed in liquid medium and the shoot was supported by
a polystyrene platform (Drake et al., 2003). After 6 weeks of
establishment in liquid culture, each group of 10 plants received
30 mL per plant of either MS or MSN (MS + 100 mM HNO3, pH
adjusted to 5.8 with NaOH). Both types of media contained 1 mg/
L a-naphthalene acetic acid (NAA; Sigma-Aldrich, Poole, UK) and
8 g/L gelatin (Sigma-Aldrich). Further 1 mg/L NAA doses (i.e.
300 lL of medium containing 100 lg/mL NAA) were added to
the medium of each individual plant at weeks 7 and 8 (Drake
et al., 2009). Medium with NAA was replaced weekly by
pipetting under sterile conditions from week 10 until week 18
—this period was named the harvesting phase. The yield of M12
in the medium recovered during these weekly collections (~25 mL
medium per plant) was determined by ELISA. The medium was
not processed in any way prior to the ELISA.
Experimental design and statistical analysis
Plants were assigned randomly to each experimental group, and
protein concentration was measured by ELISA. A normality test
(Kolmogorov–Smirnov) was performed to judge applicability of
parametric statistical analysis, and a Student’s t-test was per-
formed using the Graphpad PrismTM Software (Version 5.04;
GraphPad Software, Inc., San Diego, CA).
ELISA
For detection of M12 antibody, ELISA plates (Nunc Maxisorp;
Nunc, Roskilde, Denmark) were coated with 50 lL/well of 5 lg/
mL anti-human IgG antiserum (The Binding Site, Birmingham, UK)
diluted in PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO3,
1.5 mM KH2PO3, pH 7.5), for 2 h at 37 °C. Plates were blocked
with 2.5% w/v bovine serum albumin (BSA; Sigma-Aldrich) in PBS
with 0.1% v/v Tween 20 (BSA-PBST), 200 lL/well, for 16 h at
4 °C. After washing the plate with distilled water, serial dilutions
of samples were added alongside a known concentration of a
tobacco leaf-derived purified M12 positive control, and the plate
was incubated for 2 h at 37 °C. The plate was then washed three
times with distilled water containing 0.1% v/v Tween 20 (Sigma-
Aldrich) and incubated for 2 h at 37 °C with BSA-PBST containing
1 lg/mL of sheep HRP-conjugated anti-human-lambda light
chain antiserum (The Binding Site), 50 lL/well. Tetramethylbenz-
idine dihydrochloride peroxidase substrate was added (Sigma-
Aldrich), and the reaction was stopped with 2 M H2SO4. The
optical density was read at 450 nm on a plate reader (Tecan
SunriseTM; Tecan, Reading, UK).
Antibody concentration was calculated by interpolation of
values obtained from an IgG positive control sample titration
curve. Calculation was made using the Graphpad PrismTM
(Graphpad Software).
SDS-PAGE
Hydroponic medium samples and the purified leaf-derived
positive control were mixed with 5 lL of 4X Tris-Bis loading
buffer (Invitrogen, Life Technologies, Paisley, UK) to a final
volume of 20 lL. For reducing SDS-PAGE, 10% v/v b-mercapto-
ethanol was added to the samples. Samples were boiled for
3 min and loaded onto a 4–12% gradient Tris-Bis gel (Invitrogen).
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Samples were electrophoresed at 20 mA/gel, and visualization of
the separated proteins was performed by Coomassie brilliant blue
staining with Instant BlueTM (Expedeon, Harston, UK) or by
Western blotting.
Western blot
The gels were blotted onto nitrocellulose membrane using a semi-
dry transfer system (Hoefer; GE Healthcare, Little Chalfont, UK)
and blocked with 5% w/v nonfat dried milk in TBS/0.1% w/v
Tween 20 (milk-TBST) overnight at 4 °C. Detection was after
incubation with milk-TBST containing 1 lg/mL of sheep-derived
HRP-conjugated anti-human-lambda light chain antiserum (The
Binding Site) for 2 h at 37 °C. The blot was developed using the
ECL Plus Western blotting Detection System (GE Healthcare).
Analysis of roots by microscopy
M12 and WT plants were cultivated as described above. After
4 weeks of establishment in liquid culture, WT plants and a group
of M12 plants received 30 mL of MSN medium with 8 g/L gelatin.
Another two group of M12 plants, named M12 1NAA and M12
3NAA, received MSN medium containing 1 mg/L of NAA and
8 g/L gelatin. Further 1 mg/L NAA doses were added to individual
plants in the M12 3NAA group at weeks 5 and 6. Medium was
replaced at week 7, without NAA for the WT and M12 plants,
and with 1 mg/L NAA for the M12 1NAA and 3NAA plants. Roots
were excised from plants at week 8 and fixed at 4 °C in a 50% v/
v methanol and 10% v/v acetic acid solution. Roots were stored in
fixing solution at room temperature.
For light microscopy, fixed roots were cleared using the
following procedure. Roots were rinsed in water to remove
fixative and then put into 1% sodium dodecyl sulphate with 0.2N
NaOH overnight at room temperature. Roots were then rinsed
with water and placed into a 25% bleach solution for 5 min.
Bleached roots were rinsed in water and placed into a chloral
hydrate solution (80 g chloral hydrate in 30 mL water) overnight
at room temperature. Chloral hydrate-treated roots were trans-
ferred onto microscope slides in a polyvinyl alcohol solution
containing 75 g chloral hydrate, 2.5 g polyvinyl alcohol (average
molecular weight 85 000–124 000), 7 g glycerol and 25 mL
water. Coverslips were added, and mountant was allowed to set
for 24 h before observation by darkfield stereomicroscopy, or
brightfield compound microscopy.
Determination of total protein profile of hydroponic
medium (the rhizosecretome)
Protein separation and digestion
Hydroponic medium from M12 plants grown in MSN with NAA
was collected at week 11 and concentrated 20-fold using a
Vivaspin 2 column (Sartorius Stedim, Epsom, UK). The concen-
trated mixture was resolved by reducing SDS-PAGE and the gel
stained with Instant BlueTM (Expedeon). Stained protein bands and
seemingly blank gel regions in each lane were excised and placed
in a microtiter tray. A digesting robotic system (Projester;
Genomic Solutions, Huntingdon, UK) was set to first wash and
shrink the gel plugs using 100 mM ammonium bicarbonate
(Ambic, Witney, UK) and acetonitrile (Sigma-Aldrich). The protein
was then reduced with DTT and alkylated using iodoacetic acid.
Digestion was performed using a 3% w/v trypsin solution
(proteomics grade; Sigma) in 2 mM HCl and 10% v/v acetonitrile.
Digested peptides were extracted with 10% v/v formic acid,
frozen at 80 °C for 16 h and then freeze dried. The resulting
powder was resuspended with 30 lL of a 5% v/v acetonitrile and
0.1% v/v formic acid solution for MS analysis. Gel plugs
containing BSA were also digested alongside the experimental
samples as a system control.
Liquid chromatography—electrospray ionization—tandem
mass spectrometry (LC-ESI/MS/MS) analysis
Peptides were analysed by LC-ESI-MS/MS using a Surveyor LC
system and LCQ Deca XP Plus (Thermo Scientific, Northumber-
land, UK). Peptides were resolved by reverse phase liquid
chromatography (180 lM 9 15 mm Biobasic column; Thermo
Scientific) over a 30 min acetonitrile gradient at a flow rate of
2 lL/min. Peptides were ionized by electrospray ionization, and
MS/MS was acquired on ions dependant on their charge state and
intensity. Mass accuracy and sensitivity of the MS was confirmed
with the direct infusion of glufibrinopeptide (2.5 pmol/lL), and
LC/MS/MS performance was assessed with a digest of BSA.
Data processing
The obtained data files (.raw) were converted into mascot
generic files using the MassMatrix File Conversion Tool (Version
2.0; http://www.massmatrix.net) for input into the Mascot
searching algorithm (Matrix Science). The data files (all merged
in one search) were searched against NCBInr (v. 20080527) with
plant taxonomy parameter using the following search criteria:
tryptic peptides with up to one missed cleavage and carbami-
domethylation of cysteines and oxidation of methionines, which
were set as variable modifications. In a separate search,
individual bands were searched against an in-house database
containing sequences of the recombinant proteins. Results were
exported to Microsoft Office Excel software with a score
threshold set at 34; scores above this indicate identity or
extensive homology.
The proteins identified in each sample were ranked with the
protein with the highest mascot score listed first. The emPAI was
also calculated as previously described (Ishihama et al., 2005).
The percentage of the total protein weight contributed by each
individual protein was calculated.
Protein A affinity chromatography
Two approaches were adopted to investigate downstream
processing and purification. To process a volume of ~1 L of
hydroponic medium, coarse filtration through a 100 lM nylon
mesh filter was first used to remove particulates. The hydroponic
solution was then applied under vacuum with a flow rate of
100 mL/min. A microfiltration step was then performed using a
0.45 lM pore filter (Millipore Pelicon XL, Millipore, Watford, UK).
Ultrafiltration (UF) through a 30 kDa molecular weight cut-off
membrane (Millipore Biomax 30) was employed to reduce the
volume of the feed prior to protein A affinity chromatography.
The concentrated sample was adjusted to pH 7.4 and applied to a
packed bed protein A column (GE Healthcare). Elution was with
20 mM potassium citrate buffer (pH 3.6).
To assess the possibility of simplifying the initial preparative
steps, the pH of hydroponic medium was adjusted to 7.5 and
simply passed through a 0.22 lm filter prior to loading onto a
Protein A agarose (Sigma) packed column (BioRad, Hemel
Hempstead, UK) with a final bed volume of 500 lL. Samples
(100 mL) were loaded using a constant flow rate of 1 mL/min.
The column was washed with ≥20 column volumes of PBS, and
antibody was eluted with five column volumes of 0.1 M glycine
(pH 2.5), in 1 mL fractions. Each fraction was immediately
ª 2015 Society for Experimental Biology, Association of Applied Biologists and John Wiley & Sons Ltd, Plant Biotechnology Journal, 14, 615–624
Luisa M. Madeira et al.622
neutralized by the addition of 50 lL of 1 M Tris–HCl pH 9. For
regeneration, the column was washed extensively with 0.1 M
glycine (pH 2.5) and then with ≥10 column volumes of PBS.
MALDI analysis of N-linked glycosylation
M12 heavy chain N-linked glycosylation was purified and
sequenced by MALDI-TOF as described previously (Hakkinen
et al., 2014).
Vitronectin-binding assay
The ability of rhizosecreted M12 mAb to bind to its cognate
antigen was assessed by a vitronectin-binding ELISA. 96-well
microtiter plates were coated with human vitronectin (R&D
Systems, Abingdon, UK) to a final concentration of 500 ng/mL in
PBS, 50 lL/well and incubated at 37 °C for 2 h. Plates were
blocked with 2.5% w/v BSA in PBST, 200 lL/well, for 2 h at
37 °C and washed with distilled water containing 0.1% v/v
Tween 20. Samples were diluted to the desired concentration in
PBS, loaded on the plate in PBS, 50 lL/well and incubated for 2 h
at 37 °C. M12 produced in CHO cells (kindly provided by
Fraunhofer IME) was used as a reference. Plates were washed and
then incubated for 2 h at 37 °C with BSA-PBST containing 1 lg/
mL of sheep-derived HRP-conjugated anti-human-lambda light
chain antiserum (The Binding Site), 50 lL/well. After washing and
drying, assay was developed and the plates were read, as
described for ELISA.
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